Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Tech-based respite care for caregivers and homebound older adults

Official title: Tech-based Respite Care for Caregivers and Homebound Older Adults: A Randomized Controlled Trial

Run by Hong Kong University · NCT07160673 · Data updated 2026-11-12

This study tests whether immersive VR respite sessions help reduce depression, anxiety, loneliness, and improve quality of life for caregivers and homebound older adults more than non-immersive videos or usual care.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment180 (estimated)
SponsorHong Kong University
Academic / other
Locations1 site (Hong Kong, 香港島)
StatusRecruiting
StartedSeptember 1, 2025
Main results expectedOctober 31, 2026
Study endsAugust 28, 2027
Registry record updatedJuly 22, 2026
Trial IDNCT07160673 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are caregivers (18+) providing 6+ hours/week of care to a homebound adult 60+ who can tolerate VR, speak Cantonese, Mandarin, or English, and consent.

Probably not a fit

Individuals who do not experience improvements or who have significant motion sickness or other VR/tolerance issues may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial compares three arms: immersive VR respite, non-immersive video respite, and usual care, over four weeks. Both caregivers and their homebound older adult care recipients participate and complete assessments at baseline, after the 4-week intervention, and 3 months later. Outcomes include depression, anxiety, loneliness, quality of life, and cognitive function for care recipients, with analyses exploring differences between caregiver and recipient groups and potential moderating factors. The VR content focuses on virtual travel and social activities, delivered with trained support staff to ensure safety and engagement. Eligibility is defined for caregivers and care recipients who meet age, health, language, and VR tolerability criteria, with randomization stratified by caregiver age and recipient cognitive status.

Why it matters

Potential benefit: If successful, participants could experience reduced depressive symptoms and loneliness and an improved quality of life through engaging VR respite.

How similar studies have gone: Prior studies with similar VR respite concepts show potential benefits, but this approach with caregiver-recipient dyads and a randomized three-arm design is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Caregivers (CGs)

Inclusion Criteria:

* Aged 18 or above
* Provide care to at least one homebound older adult (aged 60 or above)
* Provide no less than 6 hours of caregiving per week
* Able to communicate in either Cantonese, Mandarin or English
* Willing to participate for the entire duration
* Able to tolerate VR headset for at least 5 minutes (no severe motion sickness/epilepsy)

Exclusion Criteria:

* History of severe psychiatric disorders (e.g., schizophrenia, bipolar)
* Severe cognitive impairment (MMSE \<10)
* Major neurological diseases (e.g., recent stroke, severe Parkinson's)
* Uncorrectable visual/hearing impairments affecting VR/video
* Unable to tolerate VR due to motion sickness or discomfort
* Care recipient receiving long-term care service that conflicts with study

Care Recipients (CRs)

Inclusion Criteria:

* Aged 60 or above
* Homebound (unable to leave home without assistance)
* Stable medical condition
* Willing to participate for the entire duration
* Able to tolerate VR headset for at least 5 minutes (no VR contraindications)
* Able to understand and provide informed consent Exclusion Criteria: Same as CGs, plus MMSE \<10

Where it's running

  • Sau Po Centre on Ageing, HKU
    Hong Kong, 香港島, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.